Erudio Healtherudio.com
Drug
Pumitamig trials: what clinicians said in public
HCP commentary reports on 3 clinical trials studying pumitamig: ROSETTA CRC-203, ROSETTA Lung-02 and ROSETTA Lung-107. Each covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| ROSETTA CRC-203 NCT07221357 · Bristol-Myers Squibb | previously untreated, unresectable or metastatic colorectal cancer | Phase 2/Phase 3 | 7 | 5 | Focused | Nov 16, 2026 | Preview |
| ROSETTA Lung-02 NCT06712316 · BioNTech SE | first-line non-small cell lung cancer | Phase 2/Phase 3 | 146 | 31 | Focused | Nov 2, 2026 | Preview |
| ROSETTA Lung-107 NCT06841055 · BioNTech SE | first- or second-line non-small cell lung cancer | Phase 2 | 13 | 4 | Focused | Nov 1, 2026 | Preview |